- Non-invasive biomarkers for liver inflammation in non-alcoholic fatty liver disease: present and future
-
Chuah KH, Chan WK
- KMID: 2541428
- Clin Mol Hepatol.
- 2023 Apr;29(2):401-403.
- doi: 10.3350/cmh.2023.0062
-
- CITED
-
- Close
- SHARE
-
- Close
- Novel and Advanced Ultrasound Techniques for Thyroid Thermal Ablation
-
Chan WK, Sun JH, Liou MJ, Hsu CJ, Lu YL, Chou WY, Li YR, Liu FH
- KMID: 2552794
- Endocrinol Metab.
- 2024 Feb;39(1):40-46.
- doi: 10.3803/EnM.2024.1917
Thyroid radiofrequency ablation and microwave ablation are widely adopted minimally invasive treatments for diverse thyroid conditions worldwide. Fundamental skills such as the trans-isthmic approach and the moving shot technique are... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison between obese and non-obese nonalcoholic fatty liver disease
-
Chan WK
- KMID: 2539790
- Clin Mol Hepatol.
- 2023 Feb;29(Suppl):S58-S67.
- doi: 10.3350/cmh.2022.0350
Nonalcoholic fatty liver disease (NAFLD) encompasses a spectrum of liver conditions that are characterized by excess accumulation of fat in the liver, and is diagnosed after exclusion of significant alcohol... -
- CITED
-
- Close
- SHARE
-
- Close
- Loss-of-function HSD17B13 variants, non-alcoholic steatohepatitis and adverse liver outcomes: Results from a multi-ethnic Asian cohort
-
Ting YW, Kong ASY, Zain SM, Chan WK, Tan HL, Mohamed Z, Pung YF, Mohamed R
- KMID: 2517632
- Clin Mol Hepatol.
- 2021 Jul;27(3):486-498.
- doi: 10.3350/cmh.2020.0162
Background/Aims: 17β-hydroxysteroid dehydrogenase 13 (HSD17B13) variants were recently reported to have significantly lower odds of non-alcoholic fatty liver disease (NAFLD). This is a two-part study that aimed to evaluate the... -
- CITED
-
- Close
- SHARE
-
- Close
